Sunshine Guojian Pharmaceutical announced that the company has signed an exclusive license agreement with Shenyang Sunshine, intending to exclusively license the company's 706, 709, HBT-2002, QY-F10, QY-F11, QY-F07, and QY-F02 projects to Shenyang Sunshine, covering the Greater China region. The transaction price includes a down payment of 2.3614 billion yuan, milestone payments, and subsequent royalties.
三生国健：与沈阳三生签署许可协议
Sunshine Guojian Pharmaceutical: signed a licensing agreement with Shenyang Sunshine.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.